This combination therapy shows the same efficacy as the basal bolus treatment regimen with respect to the glycemic control, but with a lower risk of hypoglycemia and weight gain, and is obtained with a lower dose of insulin [2, 5]. Here, INS is linked to Hypoglycemia.